跳至主要内容
临床试验/NCT01519102
NCT01519102已完成2 期

An Open-label, Randomized Two-way, Cross-over Study to Compare Meal-and-carbohydrate-announcement Strategy Versus Meal-announcement Strategy During Closed-loop Regulation of Glucose Levels in a Morning Meal in Adults With Type-1 Diabetes.

Institut de Recherches Cliniques de Montreal2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
Incremental area under the curve of plasma glucose concentration as compared to pre-meal glucose value of the postprandial glucose excursions

研究概览

简要总结

Closed-loop strategy is composed of three components: glucose sensor to read glucose levels, insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required insulin dosage based on the sensor's readings. A dual-hormone closed-loop system would regulate glucose levels through the infusion of two hormones: insulin and glucagon.

The main goal of this project is to assess whether a dual-hormone closed-loop strategy would alleviate the burden of carbohydrate counting from patients with type 1 diabetes (T1D) without a significant degradation in post-meal glucose control.

Each patient will be admitted twice to a clinical research facility. In one visit, patients will eat a morning meal accompanied with a matching insulin bolus (depending on the carbohydrate content of the meal) and glucose levels will be subsequently regulated using dual-hormone closed-loop system. In the other visit, patients will eat the same meal but will inject only a partial insulin bolus (not depending on carbohydrate content of the meal) and the remaining needed insulin will be delivered based on glucose sensor excursions as part of closed-loop operation. If post-meal glucose levels were indifferent between the two visits, then this would suggest that carbohydrate counting may not be necessary during closed-loop operation as the closed-loop system will give any remaining insulin needed to cover the glucose absorbed from the meal. Twelve subjects will be enrolled in this study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females ≥ 18 and ≤ 65 years of old.
  • Clinical diagnosis of type 1 diabetes for at least one year. The diagnosis of type 1 diabetes is based on the investigator's judgment and medical history (e.g. history of acido-ketosis, etc.); C peptide level and antibody determinations are not needed.
  • The subject will have been on insulin pump therapy for at least 3 months.
  • Last (less than 3 months) HbA1c ≤ 12%.

排除标准

  • Clinically significant nephropathy, neuropathy (especially clinically significant gastroparesis) or retinopathy as judged by the investigator.
  • Recent (< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
  • Pregnancy.
  • Severe hypoglycemic episode within two weeks of screening.
  • Medication likely to affect with the interpretation of the results: Prandase, Victoza, Byetta and Symlin
  • Known or suspected allergy to the trial products or meal contents.
  • Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
  • Failure to comply with team's recommendations (e.g. not willing to eat snack, not willing to change pump parameters, etc).
  • Unreliable carbohydrate counting
  • Problems with venous access

结局指标

主要结局

Incremental area under the curve of plasma glucose concentration as compared to pre-meal glucose value of the postprandial glucose excursions

时间窗: 0-300min

次要结局

  • Percentage of postprandial time of plasma glucose concentrations spent in the high range (above 10.0 mmol/l).(0-300 min)
  • Mean plasma glucose concentration.
  • Total insulin delivery
  • Total glucagon delivery
  • Plasma glucose concentration and incremental plasma glucose concentration at 2 hours postmeal
  • Postprandial peak and incremental postprandial peak of plasma glucose concentration
  • Percentage of time of plasma glucose concentrations spent in target range. Target range is defined to be between 4.0 and 10.0 mmol/l for 150 minutes postmeal and between 4.0 and 8.0 mmol/l afterwards
  • Percentage of postprandial time of plasma glucose concentrations spent in the low range (below 4.0mmol/l)(0-300min)

研究者

发起方
Institut de Recherches Cliniques de Montreal
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rémi Rabasa-Lhoret

Associate Professor of Medicine

Institut de Recherches Cliniques de Montreal

研究点 (2)

Loading locations...

相似试验